Major IPOs/follow-ons in cell and gene therapy by amount raised 2021
This statistic depicts the top ten initial public offerings (IPOs) and follow-ons in the cell and gene therapy industry in 2021, by amount raised. During that year, the highest offering was a follow-on offering with Intellia's raise of 690 million U.S. dollars.